Abstract:Increasing evidence demonstrates that antigen-specific cellular and humoral immunity plays an indispensable role in protection against Mycobacterium tuberculosis infection. Antigen is a key element in the development of a successful diagnostic method and vaccine. However, few antigens are available, and a systemic study on M. tuberculosis ORFeome-based antigen screening is still lacking. In the current study, a genome-wide examination was conducted on high-throughput M. tuberculosis encoding proteins and novel antigens were identified via a comprehensive investigation of serological and antigen-specific cellular responses. The serological immunoglobulin G level of each protein was detected in pooled sera from 200 pulmonary tuberculosis patients by means of semi-quantitative Western blot. Of the 1,250 detected proteins, 29 were present at a higher level relative to the commercialized 38-kDa protein. Furthermore, the top 12 of the 29 proteins had not been previously reported, and their antigenicity was validated in serum from each individual patient. Results confirmed that the 12 proteins displayed nearly identical immunoglobulin G antibody levels in patients with pulmonary and extrapulmonary tuberculosis. Antigen-specific cellular interferon-γ secretion was also evaluated using a cell-based ELISPOT assay. Thirty-four of the proteins were able to induce positive interferon-γ production by peripheral blood mononuclear cells from pulmonary tuberculosis patients as judged by positive (commercial ESAT-6 antigen) and negative controls. The top 4 candidates out of the 34 proteins displayed good accuracy ranging from 50% to 80% compared with the commercial ESAT-6 antigen. Subsequent epitope examination confirmed that a pool of peptides, including a 25aa peptide from Rv1198, demonstrated significant tuberculosis-specific cellular interferon-γ production. Overall, the current study draws significant attention to novel M. tuberculosis antigens, many of which have not been previously reported. This discovery provides a large amount of useful information for the diagnosis of tuberculosis and the development of vaccines to provide protection against tuberculosis.

Exploration of novel cellular and serological antigen biomarkers in the ORFeome of Mycobacterium tuberculosis.

ORFeome-based Identification of Biomarkers for Serodiagnosis of Mycobacterium Tuberculosis Latent Infection

Analysis of the Antigenic Properties of Membrane Proteins of Mycobacterium Tuberculosis

Enhanced Serodiagnostic Utility of Novel Mycobacterium Tuberculosis Polyproteins

A Novel Tuberculosis Antigen Identified from Human Tuberculosis Granulomas.

Identification of New Diagnostic Biomarkers for Mycobacterium Tuberculosis and the Potential Application in the Serodiagnosis of Human Tuberculosis

Antigens Rv0310c and Rv1255c Are Promising Novel Biomarkers for the Diagnosis of Mycobacterium Tuberculosis Infection.

Identification of putative biomarkers for the serodiagnosis of drug-resistant Mycobacterium tuberculosis

Immunological evaluation of a novel Mycobacterium tuberculosis antigen, Rv3117, absent in Mycobacterium bovis BCG.

Recombination, Preparation and Immunological Evaluation of Mycobacterium Tuberculosis Specific Antigen ESXO

Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens

Immunoproteomic discovery of Mycobacterium bovis antigens, including the surface lipoprotein Mpt83 as a T cell antigen useful for vaccine development

Evaluation of A Novel Fusion Protein Antigen for Rapid Serodiagnosis of Tuberculosis

Protein array identification of protein markers for serodiagnosis of Mycobacterium tuberculosis infection

High Immunogenicity of a T-Cell Epitope-Rich Recombinant Protein Rv1566c-444 From Mycobacterium tuberculosis in Immunized BALB/c Mice, Despite Its Low Diagnostic Sensitivity

Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection

Immunoproteomic Identification of Human T Cell Antigens of Mycobacterium Tuberculosis That Differentiate Healthy Contacts from Tuberculosis Patients

Immunogenicity of Whole Mycobacterium Intracellulare Proteins and Fingding on the Cross-Reactive Proteins Between M. Intracellulare and M. Tuberculosis.

Mycobacterium tuberculosis proteome microarray for global studies of protein function and immunogenicity

Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array

In Vitro and In Vivo Antigen Presentation and Diagnosis Development of Recombinant Overlapping Peptides Corresponding to Mtb ESAT-6/CFP-10